NF-kB p65 (RELA) Rabbit Polyclonal Antibody

CAT#: SP2142

NF-kB p65 (RELA) rabbit polyclonal antibody, Serum

Specifications

Product Data

• Applications: ELISA, EMSA, IHC, IP, WB
• Recommended Dilution: ELISA.
  Immunoprecipitation.
  Western Blot: 1/2000 - 1/5000.
  Gel Super Shift Assays: 0.5-1µl per test; In a gel supershift assay it was found to be active against all p65 containing human and mouse NFkB complexes using 0.5µl to 1.0µl per assay.
• Reactivities: Human, Mouse
• Host: Rabbit
• Clonality: Polyclonal
• Immunogen: NFkB p65 peptide corresponding to the C-terminus region of the human protein conjugated to KLH.
• Specificity: This antibody is reactive with NFkB p65 subunit (Rel A). A control peptide that competes specifically with the antiserum is available SP2142CP.
• Formulation: Containing 0.01% Sodium Azide
  State: Serum
  State: Liquid serum
• Storage: Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
  Avoid repeated freezing and thawing.
• Stability: Shelf life: one year from despatch.
• Database Link:
  Entrez Gene 5970 Human
• Background: NFkB (Nuclear Factor NF-kappa-B) is a pleiotropic transcription factor that plays a role in many biological processes, including inflammation, immunity, differentiation, cell growth, tumorigenesis, and apoptosis. It is found as a homo- or heterodimeric complex containing the Rel-like domain containing proteins NFkB p65 (RELA/p65), RELB, NFkB1/p105, NFkB1/p50, REL and NFkB2/p52. The heterodimeric NFkB p65/p50 complex is the most abundant one. The dimers bind to kappa-B sites at their target genes, with the affinity of the interaction dependent on the subunit composition of the dimer. Furthermore, different dimers act as transcriptional activators or repressors, with the NFkB p65/p50 and p65-c-Rel complexes acting as activators.
  NFkB activity is controlled by several different mechanisms, including post-translational modifications, subcellular localisation and interactions with other coactivators or corepressors. NFkB complexes are held in the cytoplasm in an inactive state by interaction with members of the NFkB inhibitor (IkB) family. Typically, phosphorylation of IkB by IkB kinases (IKKs) in response to different activators leads to degradation of the inhibitor, allowing NFkB to translocate into the nucleus. The inhibitory effect of IkBs is primarily exerted through their interaction with NfKB p65.
  NFkB p65 is ubiquitinated leading to its proteosomal degradation, which is required for termination of the NFkB response. Phosphorylation of NFkB p65 on S536 stimulates acetylation of K310 by CBP, enhancing transcriptional activity. NFkB p65 is also acetylated at K122, enhancing DNA binding and impairing the interaction with NFKBIA. The protein is deacetylated by HDAC3.
  Invasion of a host by a pathogen is frequently associated with the activation of NF-kB, which coordinates various aspects of immune function required for resistance to infection.
• Synonyms: NF kappa B p65, NFkB p65, Transcription factor p65, Rel A, NFKB3